New York, NYNCT07081646Now EnrollingIRB Ready

AL Amyloidosis Clinical Trial in New York, NY

Access cutting-edge al amyloidosis treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.

Sponsored by Alexion Pharmaceuticals, Inc.

Quick Self-Assessment

See if you qualify for this New York location

Preparing your pre-screening questions...

Expert Care in New York

Access al amyloidosis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related al amyloidosis treatment provided free

Apply for This New York Location

Check if you qualify for this al amyloidosis clinical trial in New York, NY

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to New York

    Convenient for NY residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit New York site if eligible
  4. 4Begin participation

About This AL Amyloidosis Study in New York

Open-label Phase 1b/2 study with primary objective of this study is to evaluate the safety, tolerability and efficacy of AZD0120 in participants with light chain (AL) amyloidosis.

Sponsor: Alexion Pharmaceuticals, Inc.

Who Can Participate

Inclusion Criteria

Confirmed histopathological diagnosis of AL amyloidosis
One or more organs currently or historically impacted by AL amyloidosis according to consensus guidelines
Measurable hematologic disease: dFLC \> 20 mg/L or serum M-protein \> 5g/L
Relapsed disease or refractory disease defined as a need for additional therapy after at least 1 line of anti-plasma cell-directed therapy.
ECOG performance status of 0 to 1
Must be able and willing to adhere to the study visit schedule and other protocol requirements
Women of child-bearing potential (WCBP) must have a negative serum pregnancy test prior to treatment. All sexually active WCBP and all sexually active male subjects must agree to use effective methods of birth control throughout the study.

Exclusion Criteria

Have any other form of amyloidosis other than AL amyloidosis
Mayo Stage IIIb AL amyloidosis
Oxygen saturation \< 95% on room air
Systolic blood pressure \<100mmHg
NYHA class III or IV

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in New York?

Yes, this clinical trial (NCT07081646) has an active research site in New York, NY that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

AL Amyloidosis Treatment Options in New York, NY

If you're searching for al amyloidosis treatment options in New York, NY, this clinical trial (NCT07081646) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced al amyloidosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all al amyloidosis clinical trials near you to find additional studies recruiting in your area.

More Amyloidosis Trials in New York, NY

See all amyloidosis clinical trials recruiting in New York — not just this study.

Browse Amyloidosis Trials in New York →

Browse More Trials by Condition

Amyloidosis TrialsOsteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in New York?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · New York, NY